GB0521083D0 - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- GB0521083D0 GB0521083D0 GBGB0521083.6A GB0521083A GB0521083D0 GB 0521083 D0 GB0521083 D0 GB 0521083D0 GB 0521083 A GB0521083 A GB 0521083A GB 0521083 D0 GB0521083 D0 GB 0521083D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- organic compounds
- compounds
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
Priority Applications (36)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0521083.6A GB0521083D0 (en) | 2005-10-17 | 2005-10-17 | Organic compounds |
ARP060104497A AR058089A1 (en) | 2005-10-17 | 2006-10-13 | LACTAMA LACTAMA COMPOUNDS |
JO2006369A JO2926B1 (en) | 2005-10-17 | 2006-10-15 | Organic Compounds |
SI200631641T SI1948643T1 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
KR1020087009098A KR101294432B1 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofuran-2-yl)pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
JP2008535948A JP5356031B2 (en) | 2005-10-17 | 2006-10-16 | 3-Alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as synthetic intermediates for renin inhibitors |
PT68288216T PT1948643E (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
PL06828821T PL1948643T3 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
PE2011001455A PE20120581A1 (en) | 2005-10-17 | 2006-10-16 | LACTAMA LACTONE DERIVATIVES AS INTERMEDIARIES IN THE SYNTHESIS OF RENIN INHIBITORS |
CA2625034A CA2625034C (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofutran-2-yl)pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
RU2008119276/04A RU2432354C2 (en) | 2005-10-17 | 2006-10-16 | Derivatives of 3-alkyl-5-(4-alkyl-5-oxotetrahydrofuran-2-yl)pyrrolidin-2-one as intermediate compounds in synthesis of renin inhibitors |
BRPI0617492-2A BRPI0617492A2 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydro-furan-2-yl) pyrrolidin-2-one derivatives and method for their preparation |
CN201210566662.6A CN103121995B (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5-(4-alkyl-5-oXo-tetrahydro furan-2-base) pyrrolidin-2-one derivatives as the intermediate of synthesis renin inhibitor |
ES06828821T ES2427098T3 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) -pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
PE2006001252A PE20070792A1 (en) | 2005-10-17 | 2006-10-16 | LACTAMA LACTONE DERIVATIVES AS INTERMEDIARIES IN THE SYNTHESIS OF RENIN INHIBITORS |
NZ567042A NZ567042A (en) | 2005-10-17 | 2006-10-16 | Processes and intermediates for the prepration of aliskiren |
PCT/EP2006/009970 WO2007045420A2 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
TW095138055A TWI395733B (en) | 2005-10-17 | 2006-10-16 | Organic compounds |
AU2006303489A AU2006303489B2 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
US12/088,457 US7772405B2 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
CA2829487A CA2829487A1 (en) | 2005-10-17 | 2006-10-16 | Organic compounds |
CN2006800035979A CN101111493B (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
DK06828821.6T DK1948643T3 (en) | 2005-10-17 | 2006-10-16 | 3-Alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
EP06828821.6A EP1948643B1 (en) | 2005-10-17 | 2006-10-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
IL190330A IL190330A (en) | 2005-10-17 | 2008-03-20 | 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofuran-2-yl)pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
ZA200802632A ZA200802632B (en) | 2005-10-17 | 2008-03-25 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
MYPI20081108A MY145466A (en) | 2005-10-17 | 2008-04-15 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
EC2008008368A ECSP088368A (en) | 2005-10-17 | 2008-04-15 | DERIVATIVES OF 3-RENT-5- (4-RENT-5-OXO-TETRAHIDROFURAN-2-IL) -PIRROLIDIN-2-ONA AS INTERMEDIARIES IN THE SYNTHESIS OF RHININE INHIBITORS |
TNP2008000170A TNSN08170A1 (en) | 2005-10-17 | 2008-04-16 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
NO20082263A NO342854B1 (en) | 2005-10-17 | 2008-05-16 | Intermediates in the synthesis of renin inhibitors, and process for their preparation. |
HK08113800.5A HK1120509A1 (en) | 2005-10-17 | 2008-12-19 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
US12/823,699 US8198465B2 (en) | 2005-10-17 | 2010-06-25 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
JP2012213001A JP5792139B2 (en) | 2005-10-17 | 2012-09-26 | 3-Alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as synthetic intermediates for renin inhibitors |
HRP20130793TT HRP20130793T1 (en) | 2005-10-17 | 2013-08-22 | 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
CY20131100754T CY1114308T1 (en) | 2005-10-17 | 2013-09-02 | Derivatives of 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofuran-2-yl) pyrrolidine-2-one as intermediate compounds at their current levels. |
JP2014105430A JP2014196312A (en) | 2005-10-17 | 2014-05-21 | Derivative of 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofuran-2-yl)pyrrolidin-2-one as synthetic intermediate for renin inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0521083.6A GB0521083D0 (en) | 2005-10-17 | 2005-10-17 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0521083D0 true GB0521083D0 (en) | 2005-11-23 |
Family
ID=35451886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0521083.6A Ceased GB0521083D0 (en) | 2005-10-17 | 2005-10-17 | Organic compounds |
Country Status (30)
Country | Link |
---|---|
US (2) | US7772405B2 (en) |
EP (1) | EP1948643B1 (en) |
JP (3) | JP5356031B2 (en) |
KR (1) | KR101294432B1 (en) |
CN (2) | CN101111493B (en) |
AR (1) | AR058089A1 (en) |
AU (1) | AU2006303489B2 (en) |
BR (1) | BRPI0617492A2 (en) |
CA (2) | CA2829487A1 (en) |
CY (1) | CY1114308T1 (en) |
DK (1) | DK1948643T3 (en) |
EC (1) | ECSP088368A (en) |
ES (1) | ES2427098T3 (en) |
GB (1) | GB0521083D0 (en) |
HK (1) | HK1120509A1 (en) |
HR (1) | HRP20130793T1 (en) |
IL (1) | IL190330A (en) |
JO (1) | JO2926B1 (en) |
MY (1) | MY145466A (en) |
NO (1) | NO342854B1 (en) |
NZ (1) | NZ567042A (en) |
PE (2) | PE20120581A1 (en) |
PL (1) | PL1948643T3 (en) |
PT (1) | PT1948643E (en) |
RU (1) | RU2432354C2 (en) |
SI (1) | SI1948643T1 (en) |
TN (1) | TNSN08170A1 (en) |
TW (1) | TWI395733B (en) |
WO (1) | WO2007045420A2 (en) |
ZA (1) | ZA200802632B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0521083D0 (en) * | 2005-10-17 | 2005-11-23 | Novartis Ag | Organic compounds |
DE102005052195A1 (en) * | 2005-10-28 | 2007-05-03 | Reuter Chemischer Apparatebau Kg | Process for the preparation of chiral octenoic acid derivatives |
CA2681203A1 (en) | 2007-04-03 | 2008-10-09 | Novartis Ag | New methods |
RU2010101236A (en) * | 2007-06-19 | 2011-07-27 | Новартис АГ (CH) | ORGANIC COMPOUNDS |
DE102007049039A1 (en) * | 2007-10-11 | 2009-04-16 | Reuter Chemischer Apparatebau Kg | Process for the preparation of 8-hydrazino-8-aryl-octanoyl derivatives and their use |
EP2189442B1 (en) * | 2008-11-20 | 2014-10-01 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process and intermediates for the preparation of aliskiren |
WO2011019789A1 (en) * | 2009-08-11 | 2011-02-17 | Novartis Ag | The ring opening of lactones and lactams |
US8203005B2 (en) * | 2009-10-29 | 2012-06-19 | Carbo Design Llc | Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren |
US20110137047A1 (en) * | 2009-12-07 | 2011-06-09 | CarboDesign LLC | Process for enantiomerically pure 8-Aryloctanoic acids as Aliskiren |
CN101774986B (en) * | 2010-01-06 | 2012-03-28 | 浙江天宇药业股份有限公司 | Method for preparing aliskiren and intermediate thereof |
CN102241650B (en) * | 2010-05-14 | 2014-05-07 | 浙江九洲药业股份有限公司 | Intermediate compound for preparing aliskiren and related preparation method |
CN102485722B (en) * | 2010-12-06 | 2014-05-07 | 博瑞生物医药技术(苏州)有限公司 | Aliskiren, its intermediates and medicinal salt, as well as preparation method thereof |
CN102775393B (en) * | 2011-05-09 | 2014-08-27 | 上海现代制药股份有限公司 | Preparation method for intermediate of medicine |
US8703976B2 (en) | 2011-10-02 | 2014-04-22 | Milan Soukup | Manufacturing process for 8-aryloctanoic acids such as Aliskiren |
CN102746182B (en) * | 2012-07-27 | 2014-09-03 | 浙江普洛医药科技有限公司 | Preparation method of Aliskiren |
CN103059012B (en) * | 2013-01-30 | 2016-06-22 | 浙江海翔药业股份有限公司 | 1,8-dicarbapentaborane-4,5-epoxide and preparation method thereof |
CN106220528B (en) * | 2014-02-28 | 2018-05-08 | 华润双鹤药业股份有限公司 | 4- positions epimer, the preparation method and the usage of aliskiren |
CN105294612A (en) * | 2014-06-05 | 2016-02-03 | 山东威智医药工业有限公司 | Aliskiren intermediate, and preparation method therefor and application thereof |
US10087190B1 (en) * | 2017-04-24 | 2018-10-02 | Purdue Research Foundation | Lactones |
CN114315749B (en) * | 2021-12-13 | 2024-04-26 | 湖南华腾医药有限公司 | Method for synthesizing aliskiren intermediate by continuous flow microreactor |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5606078A (en) * | 1994-04-18 | 1997-02-25 | Ciba-Geigy Corporation | 3,5-Disubstituted tetrahydrofuran-2-ones |
MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
US5659065A (en) | 1994-04-18 | 1997-08-19 | Novartis Corporation | Alpha-aminoalkanoic acids and reduction products |
DK1200384T3 (en) * | 1999-07-29 | 2004-08-02 | Speedel Pharma Ag | 2-Alkyl-5-halo-pent-4-encarboxylic acids and their preparation |
FR2801051B1 (en) * | 1999-11-17 | 2001-12-14 | Adir | NOVEL AMINOPYRROLINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
US6310904B1 (en) | 2000-05-31 | 2001-10-30 | Honeywell International, Inc. | Measurement method to facilitate production of self-aligning laser gyroscope block |
DE60123911T2 (en) | 2000-12-14 | 2007-05-31 | Speedel Pharma Ag | Process for the preparation of aryloctanoylamides |
EP1427702B1 (en) * | 2001-09-07 | 2006-06-14 | Basf Aktiengesellschaft | Method for the production of 2-pyrrolidone |
GB0212410D0 (en) * | 2002-05-29 | 2002-07-10 | Novartis Ag | Organic compounds |
KR20060111530A (en) | 2003-11-26 | 2006-10-27 | 노파르티스 아게 | Organic compounds |
PA8619901A1 (en) * | 2003-12-12 | 2005-11-25 | Wyeth Corp | USEFUL KINOLINES IN THE TREATMENT OF CARDIOVASCULAR DISEASES |
PL1717226T3 (en) * | 2004-03-19 | 2009-07-31 | Novartis Ag | 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension |
EP1582523A1 (en) * | 2004-04-02 | 2005-10-05 | Ludwig-Maximilians-Universität München | Method of preparing organomagnesium compounds |
GB0419361D0 (en) | 2004-08-31 | 2004-10-06 | Novartis Ag | Organic compounds |
GB0511686D0 (en) * | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
GB0521083D0 (en) * | 2005-10-17 | 2005-11-23 | Novartis Ag | Organic compounds |
-
2005
- 2005-10-17 GB GBGB0521083.6A patent/GB0521083D0/en not_active Ceased
-
2006
- 2006-10-13 AR ARP060104497A patent/AR058089A1/en not_active Application Discontinuation
- 2006-10-15 JO JO2006369A patent/JO2926B1/en active
- 2006-10-16 WO PCT/EP2006/009970 patent/WO2007045420A2/en active Application Filing
- 2006-10-16 PE PE2011001455A patent/PE20120581A1/en active IP Right Grant
- 2006-10-16 DK DK06828821.6T patent/DK1948643T3/en active
- 2006-10-16 CA CA2829487A patent/CA2829487A1/en not_active Abandoned
- 2006-10-16 PT PT68288216T patent/PT1948643E/en unknown
- 2006-10-16 ES ES06828821T patent/ES2427098T3/en active Active
- 2006-10-16 CN CN2006800035979A patent/CN101111493B/en active Active
- 2006-10-16 US US12/088,457 patent/US7772405B2/en active Active
- 2006-10-16 CN CN201210566662.6A patent/CN103121995B/en active Active
- 2006-10-16 AU AU2006303489A patent/AU2006303489B2/en not_active Ceased
- 2006-10-16 BR BRPI0617492-2A patent/BRPI0617492A2/en not_active Application Discontinuation
- 2006-10-16 SI SI200631641T patent/SI1948643T1/en unknown
- 2006-10-16 CA CA2625034A patent/CA2625034C/en not_active Expired - Fee Related
- 2006-10-16 EP EP06828821.6A patent/EP1948643B1/en active Active
- 2006-10-16 RU RU2008119276/04A patent/RU2432354C2/en not_active IP Right Cessation
- 2006-10-16 NZ NZ567042A patent/NZ567042A/en not_active IP Right Cessation
- 2006-10-16 TW TW095138055A patent/TWI395733B/en not_active IP Right Cessation
- 2006-10-16 KR KR1020087009098A patent/KR101294432B1/en active IP Right Grant
- 2006-10-16 PE PE2006001252A patent/PE20070792A1/en active IP Right Grant
- 2006-10-16 PL PL06828821T patent/PL1948643T3/en unknown
- 2006-10-16 JP JP2008535948A patent/JP5356031B2/en active Active
-
2008
- 2008-03-20 IL IL190330A patent/IL190330A/en active IP Right Grant
- 2008-03-25 ZA ZA200802632A patent/ZA200802632B/en unknown
- 2008-04-15 EC EC2008008368A patent/ECSP088368A/en unknown
- 2008-04-15 MY MYPI20081108A patent/MY145466A/en unknown
- 2008-04-16 TN TNP2008000170A patent/TNSN08170A1/en unknown
- 2008-05-16 NO NO20082263A patent/NO342854B1/en not_active IP Right Cessation
- 2008-12-19 HK HK08113800.5A patent/HK1120509A1/en not_active IP Right Cessation
-
2010
- 2010-06-25 US US12/823,699 patent/US8198465B2/en active Active
-
2012
- 2012-09-26 JP JP2012213001A patent/JP5792139B2/en active Active
-
2013
- 2013-08-22 HR HRP20130793TT patent/HRP20130793T1/en unknown
- 2013-09-02 CY CY20131100754T patent/CY1114308T1/en unknown
-
2014
- 2014-05-21 JP JP2014105430A patent/JP2014196312A/en not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0510390D0 (en) | Organic compounds | |
EP1888534A4 (en) | Organic compounds | |
GB0507575D0 (en) | Organic compounds | |
GB0500435D0 (en) | Organic compounds | |
GB0500785D0 (en) | Organic compounds | |
GB0508319D0 (en) | Organic compounds | |
GB0505969D0 (en) | Organic compounds | |
GB0502358D0 (en) | Organic compounds | |
GB0507696D0 (en) | Organic compounds | |
GB0503646D0 (en) | Organic compounds | |
GB0507577D0 (en) | Organic compounds | |
GB0507298D0 (en) | Organic compounds | |
GB0505219D0 (en) | Organic compounds | |
GB0504850D0 (en) | Organic compounds | |
GB0510810D0 (en) | Organic compounds | |
GB0504194D0 (en) | Organic compounds | |
GB0504544D0 (en) | Organic compounds | |
GB0508992D0 (en) | Organic compounds | |
GB0511060D0 (en) | Organic compounds | |
GB0501237D0 (en) | Organic compounds | |
GB0500784D0 (en) | Organic compounds | |
GB0504203D0 (en) | Organic compounds | |
GB0500683D0 (en) | Organic compounds | |
GB0507695D0 (en) | Organic compounds | |
GB0505541D0 (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |